3Grondahl - Hansensen J, Christe U, Rosenquist C, et al. High levels of urokinase type plasminogen activator and its inhibitor PAI - 1 in cytosolic exstacts of breast carcinomas are associated with poor prognosis[J]. Cancer Res, 1993,53:2513-2515. 被引量：1
4Uno S, Nakamura M, Seki T, et al. Induction of tissue - type plasminogen activator inhibitor - 1 ( PAI - 1 ) as early growth responses in rat hepatocytes in primary culture[J]. Biochem Biophys Res Commum, 1997,239: 123 - 124. 被引量：1
5Inuzuka S, Ueno T, Torimura T, et al. The significance of colocalization of plasminogen activator inhibitor- 1 and vitronectin in hepatic fibrosis [J].Scand J Ganstronterol, 1997, 32:1052 - 1055. 被引量：1
6Umeda T, Hattori T, Kodama M, et al. Cellar localization of urokinase -type plasminogen activator, its inhibitors, and their mRNA in breast cancer tissue[J] .J Pathol, 1997,183(4) :388 - 389. 被引量：1
7Kim SJ, Takai SI, Kimoto Y, et al. The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer[J]. Oncol Rep, 1998,5(2):431-433. 被引量：1
8Seki T, Imai H, Uno S, et al. Production of tissue - type plasminogen activator(t- PA) and type 1 plasminogen activator inhibitor (PAI - 1 ) in mildly cirrhotic rat liver[J]. Throb Haemost, 1996,75:801 -803. 被引量：1
9Boks AL, Brommer EJ, Schalm SW,et al. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage .Hepatology,1986 ,6:79-86. 被引量：1
10Violi F, Ferro D, Saliola M, et al. Evaluation of D-dimer in patients with liver cirrhosis.Thromb Haemost, 1989,62:1149-1150. 被引量：1
6Ziol M, Handra-Luca A, Kettaneh A,et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J]. Hepatology,2005,41:48 -54. 被引量：1
7Minoru Ayada,Tetsuya Ishikawa,Akihiko Okumura,et al.Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection[J].Hepatology Research,2006,34(4):214. 被引量：1
8Yong Xie,Hong-Xiang Sun,Duo Li.Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen[J].Vaccine,2009,27(5):757. 被引量：1
9EASL International Consensus Conference on Hepatitis B[J]. J Hepa-tol, 2003,39(suppl ) : S3-S25. 被引量：1
10Ikeda Y,Kikuchi M,Murakami H,et al.Comparison of the inhibitory effects of cilostazol,acetylsalicylic acid and ticlopidine on platelet functions exvivo.Randomized,double-blind cross-over study.Arzneimittelforschung,987,37(5):563-566. 被引量：1
